Incretins, a new strategy to treat type 2 diabetes

被引：0
|
作者：
Tan, Kimny [1 ]
Pillon, Francois [2 ]
机构：
[1] Fac Pharm, Dijon 21, France
[2] Pharm, Dijon 21, France
来源：
ACTUALITES PHARMACEUTIQUES | 2009年 / 48卷 / 481期
关键词：
D O I：
10.1016/S0515-3700(09)70012-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：21 / 22
页数：2
相关论文
共 50 条
  • [31] Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes
    Gautier, J. -F.
    Choukem, S. -P.
    Girard, J.
    DIABETES & METABOLISM, 2008, 34 : S65 - S72
  • [32] Effects of luseogliflozin on the secretion of islet hormones and incretins in patients with type 2 diabetes
    Bando, Satoru
    Ichikawa, Raishi
    Taguchi, Tomomi
    Fujimoto, Kazumi
    Motomiya, Tetsuya
    Taguchi, Madoka
    Takano, Koji
    Shichiri, Masayoshi
    Miyatsuka, Takeshi
    ENDOCRINE JOURNAL, 2022, 69 (06) : 681 - 687
  • [33] Physiological role of incretins: perspectives of treatment of patients with type 2 diabetes mellitus
    Galstyan, G. R.
    DIABETES MELLITUS, 2006, 9 (04): : 14 - 18
  • [34] The entero-insular axis in type 2 diabetes - incretins as therapeutic agents
    Creutzfeldt, W
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 : S288 - S303
  • [35] Potential of pharmacological modulation of level and activity of incretins in diabetes mellitus type 2
    Spasov A.A.
    Chepljaeva N.I.
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2014, 8 (4) : 293 - 301
  • [36] Effects of Aerobic Exercise with or without Metformin on Plasma Incretins in Type 2 Diabetes
    Eshghi, Saeed Reza Toghi
    Bell, Gordon J.
    Boule, Normand G.
    CANADIAN JOURNAL OF DIABETES, 2013, 37 (06) : 375 - 380
  • [37] Incretins and diabetes
    Inagaki, Nobuya
    ENDOCRINE JOURNAL, 2010, 57 : S203 - S203
  • [38] Incretins as a novel therapeutic strategy in patients with diabetes and heart failure
    Khan, M. A.
    Deaton, C.
    Rutter, M. K.
    Neyses, L.
    Mamas, M. A.
    HEART FAILURE REVIEWS, 2013, 18 (02) : 141 - 148
  • [39] Incretins as a novel therapeutic strategy in patients with diabetes and heart failure
    M. A. Khan
    C. Deaton
    M. K. Rutter
    L. Neyses
    M. A. Mamas
    Heart Failure Reviews, 2013, 18 : 141 - 148
  • [40] ADVANCE study : a new therapeutic strategy for type 2 diabetes?
    不详
    DIABETES & METABOLISM, 2007, 33 (05)
12345